 | • レポートコード：MRC23Q36220 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のノロウイルス診断市場について調査・分析し、世界のノロウイルス診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（迅速検査キット、PCRキット、ELISAベースキット）、用途別セグメント分析（病院、診断ラボ、クリニック）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott、R-Biopharm、ELITechGroup、Danaher Corporation (Cepheid)、Meridian Bioscience、Eiken Chemical、Altona Diagnostics、CerTest Biotec、Elisabeth Pharmacon、Qiagenなどが含まれています。世界のノロウイルス診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ノロウイルス診断市場規模を推定する際に考慮しました。本レポートは、ノロウイルス診断の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ノロウイルス診断に関するビジネス上の意思決定に役立てることを目的としています。 ・ノロウイルス診断市場の概要 - ノロウイルス診断のタイプ別セグメント - 世界のノロウイルス診断市場規模：タイプ別分析（迅速検査キット、PCRキット、ELISAベースキット） - ノロウイルス診断の用途別セグメント - 世界のノロウイルス診断市場規模：用途別分析（病院、診断ラボ、クリニック） - 世界のノロウイルス診断市場規模予測（2018年-2029年） ・ノロウイルス診断市場の成長トレンド - ノロウイルス診断の地域別市場規模（2018年-2029年） - ノロウイルス診断市場ダイナミクス - ノロウイルス診断の業界動向 - ノロウイルス診断市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：迅速検査キット、PCRキット、ELISAベースキット - 世界のノロウイルス診断のタイプ別市場規模（2018年-2023年） - 世界のノロウイルス診断のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診断ラボ、クリニック - 世界のノロウイルス診断の用途別市場規模（2018年-2023年） - 世界のノロウイルス診断の用途別市場規模（2024年-2029年） ・ノロウイルス診断の地域別市場規模 - 北米のノロウイルス診断市場規模（2018年-2029年） - アメリカのノロウイルス診断市場規模（2018年-2029年） - ヨーロッパのノロウイルス診断市場規模（2018年-2029年） - アジア太平洋のノロウイルス診断市場規模（2018年-2029年） - 中国のノロウイルス診断市場規模（2018年-2029年） - 日本のノロウイルス診断市場規模（2018年-2029年） - 韓国のノロウイルス診断市場規模（2018年-2029年） - インドのノロウイルス診断市場規模（2018年-2029年） - オーストラリアのノロウイルス診断市場規模（2018年-2029年） - 中南米のノロウイルス診断市場規模（2018年-2029年） - 中東・アフリカのノロウイルス診断市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Abbott、R-Biopharm、ELITechGroup、Danaher Corporation (Cepheid)、Meridian Bioscience、Eiken Chemical、Altona Diagnostics、CerTest Biotec、Elisabeth Pharmacon、Qiagen ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Norovirus Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Norovirus Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Norovirus Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Norovirus Diagnostics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Norovirus Diagnostics include Abbott, R-Biopharm, ELITechGroup, Danaher Corporation (Cepheid), Meridian Bioscience, Eiken Chemical, Altona Diagnostics, CerTest Biotec and Elisabeth Pharmacon, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Norovirus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Norovirus Diagnostics.
The Norovirus Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Norovirus Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Norovirus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott
R-Biopharm
ELITechGroup
Danaher Corporation (Cepheid)
Meridian Bioscience
Eiken Chemical
Altona Diagnostics
CerTest Biotec
Elisabeth Pharmacon
Qiagen
Segment by Type
Rapid Test Kits
PCR Kits
ELISA Based Kits
Segment by Application
Hospitals
Diagnostics Labs
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Norovirus Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Norovirus Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Test Kits
1.2.3 PCR Kits
1.2.4 ELISA Based Kits
1.3 Market by Application
1.3.1 Global Norovirus Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostics Labs
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Norovirus Diagnostics Market Perspective (2018-2029)
2.2 Norovirus Diagnostics Growth Trends by Region
2.2.1 Global Norovirus Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Norovirus Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Norovirus Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Norovirus Diagnostics Market Dynamics
2.3.1 Norovirus Diagnostics Industry Trends
2.3.2 Norovirus Diagnostics Market Drivers
2.3.3 Norovirus Diagnostics Market Challenges
2.3.4 Norovirus Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Norovirus Diagnostics Players by Revenue
3.1.1 Global Top Norovirus Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Norovirus Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Norovirus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Norovirus Diagnostics Revenue
3.4 Global Norovirus Diagnostics Market Concentration Ratio
3.4.1 Global Norovirus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Norovirus Diagnostics Revenue in 2022
3.5 Norovirus Diagnostics Key Players Head office and Area Served
3.6 Key Players Norovirus Diagnostics Product Solution and Service
3.7 Date of Enter into Norovirus Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Norovirus Diagnostics Breakdown Data by Type
4.1 Global Norovirus Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Norovirus Diagnostics Forecasted Market Size by Type (2024-2029)
5 Norovirus Diagnostics Breakdown Data by Application
5.1 Global Norovirus Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Norovirus Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Norovirus Diagnostics Market Size (2018-2029)
6.2 North America Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Norovirus Diagnostics Market Size by Country (2018-2023)
6.4 North America Norovirus Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Norovirus Diagnostics Market Size (2018-2029)
7.2 Europe Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Norovirus Diagnostics Market Size by Country (2018-2023)
7.4 Europe Norovirus Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Norovirus Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Norovirus Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Norovirus Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Norovirus Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Norovirus Diagnostics Market Size (2018-2029)
9.2 Latin America Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Norovirus Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Norovirus Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Norovirus Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Norovirus Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Norovirus Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Norovirus Diagnostics Introduction
11.1.4 Abbott Revenue in Norovirus Diagnostics Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 R-Biopharm
11.2.1 R-Biopharm Company Detail
11.2.2 R-Biopharm Business Overview
11.2.3 R-Biopharm Norovirus Diagnostics Introduction
11.2.4 R-Biopharm Revenue in Norovirus Diagnostics Business (2018-2023)
11.2.5 R-Biopharm Recent Development
11.3 ELITechGroup
11.3.1 ELITechGroup Company Detail
11.3.2 ELITechGroup Business Overview
11.3.3 ELITechGroup Norovirus Diagnostics Introduction
11.3.4 ELITechGroup Revenue in Norovirus Diagnostics Business (2018-2023)
11.3.5 ELITechGroup Recent Development
11.4 Danaher Corporation (Cepheid)
11.4.1 Danaher Corporation (Cepheid) Company Detail
11.4.2 Danaher Corporation (Cepheid) Business Overview
11.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Introduction
11.4.4 Danaher Corporation (Cepheid) Revenue in Norovirus Diagnostics Business (2018-2023)
11.4.5 Danaher Corporation (Cepheid) Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Detail
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Norovirus Diagnostics Introduction
11.5.4 Meridian Bioscience Revenue in Norovirus Diagnostics Business (2018-2023)
11.5.5 Meridian Bioscience Recent Development
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Detail
11.6.2 Eiken Chemical Business Overview
11.6.3 Eiken Chemical Norovirus Diagnostics Introduction
11.6.4 Eiken Chemical Revenue in Norovirus Diagnostics Business (2018-2023)
11.6.5 Eiken Chemical Recent Development
11.7 Altona Diagnostics
11.7.1 Altona Diagnostics Company Detail
11.7.2 Altona Diagnostics Business Overview
11.7.3 Altona Diagnostics Norovirus Diagnostics Introduction
11.7.4 Altona Diagnostics Revenue in Norovirus Diagnostics Business (2018-2023)
11.7.5 Altona Diagnostics Recent Development
11.8 CerTest Biotec
11.8.1 CerTest Biotec Company Detail
11.8.2 CerTest Biotec Business Overview
11.8.3 CerTest Biotec Norovirus Diagnostics Introduction
11.8.4 CerTest Biotec Revenue in Norovirus Diagnostics Business (2018-2023)
11.8.5 CerTest Biotec Recent Development
11.9 Elisabeth Pharmacon
11.9.1 Elisabeth Pharmacon Company Detail
11.9.2 Elisabeth Pharmacon Business Overview
11.9.3 Elisabeth Pharmacon Norovirus Diagnostics Introduction
11.9.4 Elisabeth Pharmacon Revenue in Norovirus Diagnostics Business (2018-2023)
11.9.5 Elisabeth Pharmacon Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Norovirus Diagnostics Introduction
11.10.4 Qiagen Revenue in Norovirus Diagnostics Business (2018-2023)
11.10.5 Qiagen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details